4//SEC Filing
Colonno Richard James 4
Accession 0001209191-19-060710
CIK 0001426800other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:17 PM ET
Size
9.7 KB
Accession
0001209191-19-060710
Insider Transaction Report
Form 4
Colonno Richard James
Chief Science Officer
Transactions
- Exercise/Conversion
Common Stock
2019-12-12$7.03/sh+33,061$232,419→ 160,882 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-12−33,061→ 166,939 totalExercise: $7.03Exp: 2026-01-11→ Common Stock (33,061 underlying) - Sale
Common Stock
2019-12-12$25.00/sh−33,061$826,578→ 127,821 total
Footnotes (4)
- [F1]The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 532, 1,000 and 39 shares acquired under the Assembly Biosciences, Inc. 2018 Employee Stock Purchase Plan on November 14, 2018, May 14, 2019 and November 14, 2019, respectively.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.035, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- [F4]This option represents a right to purchase 200,000 shares. As of January 5, 2019, 150,000 stock options have vested. The remaining options vest on January 5, 2020.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001663018
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:17 PM ET
- Size
- 9.7 KB